Ambenonium chloride
Overview of the drug Ambenonium chloride
Ambenonium chloride is a medication used in the management of myasthenia gravis, a chronic autoimmune neuromuscular disease characterized by varying degrees of weakness of the skeletal muscles. It is classified as a cholinesterase inhibitor, which works by increasing the levels of acetylcholine at the neuromuscular junction, thereby improving muscle contraction.
Mechanism of Action[edit]
Ambenonium chloride functions by inhibiting the enzyme acetylcholinesterase, which is responsible for breaking down acetylcholine in the synaptic cleft. By preventing the degradation of acetylcholine, ambenonium chloride enhances neuromuscular transmission and improves muscle strength in patients with myasthenia gravis.
Pharmacokinetics[edit]
Ambenonium chloride is administered orally and is absorbed through the gastrointestinal tract. The onset of action typically occurs within 30 to 60 minutes, and the duration of effect can last from 3 to 8 hours, depending on the individual patient's response and the severity of the condition.
Clinical Use[edit]
Ambenonium chloride is primarily used in the treatment of myasthenia gravis. It is often prescribed when patients do not respond adequately to other cholinesterase inhibitors such as pyridostigmine or neostigmine. The dosage of ambenonium chloride must be carefully adjusted to achieve optimal therapeutic effects while minimizing side effects.
Side Effects[edit]
Common side effects of ambenonium chloride include nausea, diarrhea, abdominal cramps, and increased salivation. In some cases, patients may experience muscle cramps, sweating, and bradycardia. Overdosage can lead to a cholinergic crisis, characterized by severe muscle weakness, respiratory distress, and potentially life-threatening symptoms.
Contraindications[edit]
Ambenonium chloride is contraindicated in patients with mechanical intestinal obstruction or urinary tract obstruction. Caution is advised in patients with asthma, epilepsy, cardiovascular disease, and peptic ulcer disease.
Image[edit]

Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian